Your one stop place for all the latest ReGen Factor news and updates on progress with product developments, FDA trials, ASX listing, Industry News and Scientific Studies.
Stephen Blignaut, Brookvale NSW 2100 Australia August 5, 2024 Overview of Basic Fibroblast Growth Factor (bFGF) Basic Fibroblast Growth Factor (bFGF), also known as
FOR IMMEDIATE RELEASE ReGen Factor’s Advanced Memory Factor: Harnessing Alpha-GPC and Neurotrophic Factors to Combat Brain Health Issues Australia – August 1, 2024 – ReGen
FOR IMMEDIATE RELEASE ReGen Factor to Seek FDA Approval for Groundbreaking Diabetic Ulcer Treatment Utilizing Bio-Identical Fibroblast Growth Factor (bFGF) Australia – August 1, 2024
Press Release: ReGen Factor Announces New PET NMN Supplement for Dogs and Cats 25 July 2024 Sydney, Australia – ReGen Factor, a leading innovator in
New Cancer Vaccine under Investigation by ReGen Factor Table of Contents 1. What is the WT1 Anti-Cancer Peptide 2. Clinical Evidence Related to WT1 3.
Report to Dr. Jones 15 July 2024 Basic fibroblast growth factor (bFGF) can be applied to the fallopian tubes as a therapeutic agent aimed at
Age Reversal Breakthrough Scientists from Harvard Medical School, the University of Maine, and MIT have published a groundbreaking study revealing a chemical method to reprogram
Report to Dr. Jones Basic Fibroblast Growth Factor (bFGF) in Infertility Treatment: A Comprehensive Review Introduction Infertility affects a significant portion of the global
NMN and Exosome Research in Veterinary Applications 25 June 2024 Sydney, Australia by Claire Ironside Abstract This paper explores the implications of Nicotinamide Mononucleotide (NMN)
Welcome to ReGen Factor’s latest quarterly update. Since our last update in May 2022, we have made significant strides towards achieving our goals. This update
